서방형제제 분할처방에 대한 건강보험심사제도의 효과와 장애요인
Impact and Barriers of the Health Insurance Review on Splitting Extended-Release Formulation Drugs
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Health insurance review & Assessment service (HIRA) has enforced cutting the drug costs when physicians prescribe split extended release drugs, starting from December, 2010. The objective of this study is to analyze extended release and enteric coated drugs on pharmaceutical reimbursement list in Korea, and to investigate the impact and barriers of the health insurance review on splitting extended-release formulation drugs. By using the ingredient code, extended release and enteric coated formulations make up 7.8% of all drugs in April, 2011. The most frequently used drugs are agent affecting circulatory and digestive system. From the extended release and enteric coated formulations (n=112),34.8% (n=39) were not available in other dosage forms. According to questionnaire survey for 169 pharmacists (response rate: 73.8%), the rate of splitting and crushing of extended release and enteric coated drugs decreased. When pharmacists correct physician’s prescription errors, the biggest problem was lack of other dosage forms. So it is necessary to develop variety of other dosage forms, and computerized checking system for splitting extended-release drugs. It is also important to inform physicians and patients in regard to the problems of split prescription of extended release and enteric coated drugs.
Abstract
Health insurance review & Assessment service (HIRA) has enforced cutting the drug costs when physicians prescribe split extended release drugs, starting from December, 2010. The objective of this study is to analyze extended release and enteric coated drugs on pharmaceutical reimbursement list in Korea, and to investigate the impact and barriers of the health insurance review on splitting extended-release formulation drugs. By using the ingredient code, extended release and enteric coated formulations make up 7.8% of all drugs in April, 2011. The most frequently used drugs are agent affecting circulatory and digestive system. From the extended release and enteric coated formulations (n=112),34.8% (n=39) were not available in other dosage forms. According to questionnaire survey for 169 pharmacists (response rate: 73.8%), the rate of splitting and crushing of extended release and enteric coated drugs decreased. When pharmacists correct physician’s prescription errors, the biggest problem was lack of other dosage forms. So it is necessary to develop variety of other dosage forms, and computerized checking system for splitting extended-release drugs. It is also important to inform physicians and patients in regard to the problems of split prescription of extended release and enteric coated drugs.
참고문헌 (13)
- 이범진, "제형의 원리와 기술", pp.541~564 (2002), 신일상사
- Aronson JK, "Medication errors: what they are, how they happen, and how to avoid them", QJM, 102, pp.513~521 (2009)
- Cornish P, "Avoid the crush: hazards of medication administration in patients with dysphagia or feeding tube", CMAJ, 172, pp.871~872 (2005)
- David W, "Swallowing difficulties protocol: medication administration", Nursing Standard, 17, pp.14~15 (2002)
- Quinzler R, "The frequency of inappropriate tablet splitting in primary care", Eur J Clin Pharmacol, 62, pp.1065~1073 (2006)
- Lesar TS, "Medication prescribing errors involving the route of administration", Hospital Pharmacy, 41, pp.1053~1066 (2006)
- Lesar TS, "Prescribing errors involving medication dosage forms", JGIM, 17, pp.579~587 (2002)
- 이의경, "의원의 건강보험청구자료를 이용한 고형경구제 분할 처방 분석", Journal of Pharmaceutical Investigation, 37(2), pp.119~126 (2007), 한국약제학회
- Quinzler R, "Substantial reduction of inappropriate tablet splitting with computerized decision support: a prospective intervention study assessing potential benefit and harm", BMC Medical informatics and Decision Making, 9, pp.1472~6947 (2009)
- Quinzler R, "Tablet splitting: patients and physicians need better support", Eur J Clin Pharmacol, 63, pp.1203~1204 (2007)
- 곽필임, "조제과오 예방교육이 병원약국의 조제과오 발생율에 미치는 영향", 한국임상약학회지, 18(1), pp.1~5 (2008), 한국임상약학회
- Building a safer NHS for patients: improving medication safety, "Smith J", NHS, ~ (2004)
- 오준희, "분쇄불가 정제의 유효성 향상 방안에 관한 연구", 병원약사회지, 24(3), pp.1~16 (2007), 한국병원약사회